Merck (MRK) Income from Non-Controlling Interests (2009 - 2026)

Merck has disclosed Income from Non-Controlling Interests across 18 years of filings, most recently posting -$3.0 million for Q1 2026.

• In Q1 2026, Income from Non-Controlling Interests fell 150.0% year-over-year to -$3.0 million; the TTM figure through Mar 2026 stood at -$1.0 million (down 105.88% YoY), while the FY2025 annual figure was $9.0 million, down 43.75% from the prior year.
• Income from Non-Controlling Interests declined to -$3.0 million in Q1 2026, from -$1.0 million in the prior quarter.
• Over the last five years, Income from Non-Controlling Interests for MRK reached as high as $6.0 million in Q2 2024 and fell as low as -$3.0 million in Q1 2022.
• The 5-year median for Income from Non-Controlling Interests is $3.5 million (2023), against an average of $2.6 million.
• Annual changes were most pronounced in 2022 — Income from Non-Controlling Interests surged 400.0% — and 2025, when it slumped 200.0%.
• A 5-year view of Income from Non-Controlling Interests shows it stood at $1.0 million in 2022, then surged by 400.0% to $5.0 million in 2023, then plunged by 80.0% to $1.0 million in 2024, then tumbled by 200.0% to -$1.0 million in 2025, then tumbled by 200.0% to -$3.0 million in 2026.
• According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered -$3.0 million, -$1.0 million, and $2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.